Learn More
Medchemexpress LLC Strontium Ranelate | 135459-87-9 | 99.99% | 513.49 | 5 G

Supplier: Medchemexpress LLC HY173975G
Strontium Ranelate is an antiosteoporotic agent that reduces bone resorption and promotes bone formation, leading to a positive bone balance. It activates the calcium-sensing receptor (CaSR) in non-skeletal cells, initiating inositol 1, 4, 5-triphosphate production and mitogen-activated protein kinase signaling. For research use only.
- Reduces bone resorption and promotes bone formation.
- Induces a positive bone balance.
- Activates calcium-sensing receptor (CaSR) in non-skeletal cells.
- Increases early and late osteoblast markers (ALP, OCN) in mouse calvaria cells in vitro.
- Increases alkaline phosphatase activity and prostaglandin E2 production.
- Increases bone mass in vertebrae and lumbar/femur in adult mice and rats in vivo.
- Decreases bone resorption and increases bone formation in alveolar bone.
- Prevents trabecular bone loss in ovariectomized rats, improving bone strength.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.